Trial intelligence / Profile preview

Quality of Life Before and After Epithelial Stem Cell Transplantation in Severe Ocular Surface Disease

TCTR20230206005Completed

Sponsor
Department of Ophthalmology, Faculty of Medicine Siriraj Hospital
Start
Dec 2018
Countries
1
01

Overview

Open-label, single-arm trial in ocular surface disease (OSD), sponsored by Department of Ophthalmology, Faculty of Medicine Siriraj Hospital. Primary endpoint: Quality of life change. Started Dec 2018; status: completed.

02

Conditions

ocular surface disease (OSD)

Beyond the preview

Go deeper on TCTR20230206005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230206005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call